Tag: First Quarter (Q1)
Resmed targets ‘strong execution’ in marketing
October 30, 2026Liz Beaulieu, Editor
SAN DIEGO – Resmed is betting that a growing slate of consumer marketing programs and partnerships will help it reach the high end of its 5% to 7% core constant currency revenue growth target for fiscal year 2027.
The initiatives did not contribute materially to first-quarter results, but CEO Mick Farrell says efforts to raise awareness of sleep apnea and encourage patients to seek treatment can help drive longer-term growth.
“(CFO Aaron Bloomer) talked about what would get us to...
Resmed CEO: ‘We began fiscal year 2027 with a strong first quarter’
October 29, 2026HME News Staff
SAN DIEGO – Resmed reported revenue increased 6% to $1.4 billion in the first quarter of fiscal year 2027.
On a core constant currency basis, Americas Sleep and Breathing Health revenue grew 7%, Rest of World Sleep and Breathing Health grew 8% and Residential Care Software revenue increased 5%.
“We began fiscal year 2027 with a strong first quarter, driven by continued global demand for our sleep and breathing health solutions and ongoing execution across our business,” said...
McKesson signals next phase for MMS with new name
August 7, 2026Liz Beaulieu, Editor
IRVING, Texas – McKesson’s Medical-Surgical Solutions business plans to formally operate as Wellverse starting in January 2027, as part of a phased transition, says McKesson CEO Brian Tyler.
The company announced the new name on Aug. 5 as part of its financial results for the first quarter of fiscal year 2027.
“Wellverse delivers a future where health care providers and patients thrive,” Tyler said during a conference call to discuss the results. “This is an important...
Accendra Health reports Q1, announces $1.5B optimization
May 11, 2026HME News Staff
RICHMOND, Va. – Accendra Health reported $627.8 million for the first quarter of 2026 vs. $673.9 million for the same period last year. Adjusted EBITDA was $58.4 million vs. $96 million.
Unless otherwise noted, the results reflect Accendra’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. The company ended the fourth quarter of 2025 by selling its Products & Healthcare Services (P&HS) business to Platinum...
Medline positions for sustained growth
May 11, 2026HME News Staff
NORTHFIELD, Ill. – Medline reported net sales of $7.4 billion for the first quarter of 2026, a 10.7% increase. Net income was $239 million, a 25.8% decrease.
Other financial results:
Adjusted EBITDA of $776 million, a decrease of 10.6%.
Diluted earnings per share and adjusted diluted EPS were $0.16 and $0.33, respectively.
Net cash provided by operating activities in the first quarter 2026 was $412 million, driven by net income, excluding the impact of non-cash items, partially...
Inogen credits ‘power of our strategy’
May 7, 2026HME News Staff
BEVERLY, Mass. - Inogen reported total revenue of $85.1 million for the first quarter of 2026, a 3.4% increase compared to the prior-year period, ahead of the company’s expectations.
Other financial results
Total gross margin was 44.5% in the first quarter of 2026 compared to 44.2% in the prior-year period. Adjusted gross margin improved by 30 basis points to 44.7% compared to 44.4% in the prior-year period due to cost improvements in the total cost of revenue.
GAAP net loss for...
AdaptHealth sets stage for ‘defining year’
May 5, 2026HME News Staff
CONSHOHOCKEN, Pa. – AdaptHealth reported revenue of $819.8 million for the first quarter ended March 31, 2026, an increase of 5.4% over the same period the prior year.
Other financial results
Organic revenue growth of 9.1%, with growth across each of the reportable Segments.
Net loss attributable to AdaptHealth Corp. was $16.0 million compared to net loss of $7.2 million.
Adjusted EBITDA was $121.2 million compared to $127.9 million, a decrease of 5.3%.
Cash flow from operations...
Resmed says it’s off to a strong start with 9% increase in revenue
October 30, 2025HME News Staff
SAN DIEGO – Resmed reported revenue of $1.9 billion for the first quarter of fiscal year 2026, a 9% increase compared to the same period in 2025.
“Our fiscal year 2026 is off to a strong start, with first-quarter performance reflecting continued progress toward our mission of helping people sleep better, breathe better and live longer and healthier, with care provided in their own home,” said Resmed’s Chairman and CEO Mick Farrell.
Other financial results:
Gross...
Inogen: ‘We feel we’re in a good position’
May 14, 2025Liz Beaulieu, Editor
GOLETA, Calif. – Given the company’s current exemptions, Inogen does not anticipate material impact on its operating plan or financial profile from announced tariffs.
Inogen, which recently announced a distribution agreement with Yuwell in China, believes it’s well positioned to continue executing on its strategic priorities despite these developments.
“However, the situation is dynamic, and we will continue to monitor it closely,” said Kevin Smith,...
InfuSystem positioned for ‘successful year’
May 12, 2025HME News Staff
ROCHESTER HILLS, Mich. - InfuSystem Holdings has reported net revenues of $34.7 million for the first quarter of 2025, a 9% increase compared to the same period last year. Of that, Patient Services net revenue was $20.8 million, a 12% increase, and Device Solutions was $13.9 million, a 4% increase. It reported net loss of $300,000 this year vs. $1.1 million last year. “I’m very pleased to report 2025 is off to an excellent start demonstrating solid growth,” said Richard Dilorio,...